Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Citadel Group Major Shareholding Notification 2020

Sep 17, 2020

10454_mrq_2020-09-17_463695d4-2f09-487b-a933-f7905d367d47.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 3397Z

Citadel Group

17 September 2020

Ap 19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.         KEY INFORMATION

Name of person dealing (Note 1)

Citadel Group

Company dealt in

WILLIS TOWERS WATSON PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

Common Stock ISIN IE00BDB6Q211

Date of dealing

16 September, 2020

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security

dealt in (Note 3)

Long Short
Common Stock  ISIN  IE00BDB6Q211 Number        (%) Number      (%)
(1) Relevant securities 523,580 (0.41%) 45 (0.00%)
(2) Derivatives (other than options) 1,476,621 (1.15%) 0 (0.00%)
(3) Options and agreements to purchase/sell 0 (0.00%) 0 (0.00%)
Total 2,000,201(1.55%) 45 (0.00%)

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Long Short
Number        (%) Number      (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap 20

1.         DEALINGS (Note 4)

(a)        Purchases and sales

Purchase/sale

Common Stock ISIN IE00BDB6Q211
Number of securities Price per unit (Note 5)
Purchase 26 206.75730769  USD
Purchase 15 206.77466667  USD
Purchase 137 206.94  USD
Purchase 220 207.84636364  USD
Purchase 1 208.1  USD
Purchase 763 208.2144692  USD
Purchase 10 208.28  USD
Purchase 5 208.384  USD
Purchase 137 208.42978102  USD
Purchase 2,062 208.4393162  USD
Purchase 462 208.45556277  USD
Purchase 1,097 208.49369189  USD
Purchase 100 208.5  USD
Purchase 100 208.555  USD
Purchase 100 208.56  USD
Purchase 155 208.59  USD
Purchase 9 208.73  USD
Purchase 100 208.75  USD
Purchase 63 208.75055556  USD
Purchase 100 208.86  USD
Purchase 10 208.89  USD
Purchase 10 209.23  USD
Sale 1,170 206.94  USD
Sale 101 207.45990099  USD
Sale 15 207.46  USD
Sale 100 207.66  USD
Sale 152 207.81368421  USD
Sale 7 207.99  USD
Sale 221 208.02484163  USD
Sale 578 208.23972318  USD
Sale 584 208.25280822  USD
Sale 131 208.26175573  USD
Sale 2,427 208.27208076  USD
Sale 203 208.38684729  USD
Sale 39 208.562821  USD
Sale 28 208.563214  USD
Sale 192 208.56770833  USD
Sale 40 208.6175  USD
Sale 57 208.61807  USD

(b)        Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

 ISIN
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c)        Options transactions in respect of existing relevant securities

(i)         Writing, selling, purchasing or varying

Product name, e.g. call option Writing, selling, purchasing,

varying etc.
Number of securities to which the option relates (Note 7) Exercise price Type,

e.g. American, European etc.
Expiry date Option money paid/ received per unit

(Note 5)

(ii)        Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit

(Note 5)

(d)        Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

      (if applicable) (Note 5)

Ap 21

2.         OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated
None

Is a Supplemental Form 8 attached? (Note 9)

NO

Date of disclosure: 17 September, 2020
Contact name: Kim Heslop
Telephone number: 020 7645 9700
If a connected EFM, name of offeree/offeror with which connected n/a
If a connected EFM, state nature of connection (Note 10) n/a

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEGPUAPBUPUGWM